Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress

Cancer is a major global concern due to its high mortality rate. Tumor immunotherapy has revolutionized cancer treatment. However, low response rates and immune-related complications remain challenges. Extracellular vesicles (EVs), including exosomes, have emerged as promising therapeutic tools for various pathological conditions, especially cancer. Evidence indicates that changes in the quantity and composition of EVs can influence the immunosuppressive tumor microenvironment, potentially affecting the effectiveness of immunotherapy. Exploiting EVs for immune sensitization has generated significant clinical interest. This review provides an in-depth understanding of the origin of EVs, their therapeutic applications (such as drug delivery nanoplatforms and cancer immunotherapies, including vaccines), diagnostic potential as tumor biomarkers, ongoing EV-based clinical trials, and the challenges encountered in EV-based cancer immunotherapy.

Authors

Institutions

Publication Details

Journal
Asian Journal of Pharmaceutical Sciences
Published
2025-05-09
DOI
https://doi.org/10.1016/j.ajps.2025.101065
Citations
2
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress

Sahar Khosravi, Piao Yang, Hamed Manoochehri, Hanie Mahaki et al.
2 citations
Asian Journal of Pharmaceutical Sciences
Extracellular vesicles in disease
1.61
article

Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress

Sahar Khosravi, Piao Yang, Hamed Manoochehri, Hanie Mahaki, Hamid Tanzadehpanah, Anita Silas La’ah, Ali Babaeizad, Mohsen Sheykhhasan, Fariba Nikravesh, Mohadeseh Rostamipoor, Mahdiyeh Abbaspoor
article en
2 citations

Abstract

Cancer is a major global concern due to its high mortality rate. Tumor immunotherapy has revolutionized cancer treatment. However, low response rates and immune-related complications remain challenges. Extracellular vesicles (EVs), including exosomes, have emerged as promising therapeutic tools for various pathological conditions, especially cancer. Evidence indicates that changes in the quantity and composition of EVs can influence the immunosuppressive tumor microenvironment, potentially affecting the effectiveness of immunotherapy. Exploiting EVs for immune sensitization has generated significant clinical interest. This review provides an in-depth understanding of the origin of EVs, their therapeutic applications (such as drug delivery nanoplatforms and cancer immunotherapies, including vaccines), diagnostic potential as tumor biomarkers, ongoing EV-based clinical trials, and the challenges encountered in EV-based cancer immunotherapy.

Asian Journal of Pharmaceutical SciencesVol. 20(5)
National Yang Ming Chiao Tung University (TW), Mashhad University of Medical Sciences (IR), Shahid Sadoughi University of Medical Sciences and Health Services (IR), Kerman University of Medical Sciences (IR), Columbus College of Art and Design (US), Institute of Molecular Biology, Academia Sinica (TW), Semnan University of Medical Sciences (IR), Bushehr University of Medical Sciences (IR), Qom University of Medical Science and Health Services (IR), Persian Gulf University (IR)
Good health and well-being
Openalex Percentile: Top 17%
Extracellular vesicles in disease
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.